Polly J Hoppin
Biographic Data
| ID | 6072349 |
|---|---|
| NAME | Polly J Hoppin |
| GIVEN NAMES | Polly J |
| FAMILY NAME | Hoppin |
| SIGNATURE | HOPPIN P J |
| AFFILIATIONS | Polly J. Hoppin is with the Environmental Health Initiative of the Lowell Center for Sustainable Production at the School of Health and Environment, University of Massachusetts, Lowell, Mass. Richard Clapp is with the Department of Environmental Health, Boston University School of Public Health, Boston, Mass. |
| VERIFIED | No |
| TOTAL WORKS | 1 |
| TOTAL CITATIONS | 1 |
| AUTHOR COUNT | 1 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2005 |
| LATEST PUBLICATION YEAR | 2005 |
| H-INDEX | 1 |
Science and Regulation
We reflect on four articles that examine the Supreme Court’s Daubert v Merrell Dow Pharmaceuticals, Inc decision and efforts by private interests to derail public health and environmental regulations. The articles’ authors make the case that the impact of Daubert and related decisions in court settings pale by comparison to the threat that Daubert-like thinking poses in the regulatory arena. A growing number of companies, however, have made subst…
Science and Regulation
We reflect on four articles that examine the Supreme Court’s Daubert v Merrell Dow Pharmaceuticals, Inc decision and efforts by private interests to derail public health and environmental regulations. The articles’ authors make the case that the impact of Daubert and related decisions in court settings pale by comparison to the threat that Daubert-like thinking poses in the regulatory arena. A growing number of companies, however, have made subst…
Science and Regulation
We reflect on four articles that examine the Supreme Court’s Daubert v Merrell Dow Pharmaceuticals, Inc decision and efforts by private interests to derail public health and environmental regulations. The articles’ authors make the case that the impact of Daubert and related decisions in court settings pale by comparison to the threat that Daubert-like thinking poses in the regulatory arena. A growing number of companies, however, have made subst…
Biomedical Ethics and Regulation (1 works) · Business (1 works) · Economics (1 works) · Environmental ethics (1 works) · Ingenuity (1 works) · Law (1 works) · Pharmaceutical industry and healthcare (1 works) · Pledge (1 works) · Political science (1 works) · Public Administration (1 works)